Skip to main content
Top
Published in: Malaria Journal 1/2019

Open Access 01-12-2019 | Antimalaria | Research

Quantitative structure–activity relationship to predict the anti-malarial activity in a set of new imidazolopiperazines based on artificial neural networks

Authors: Saeed Yousefinejad, Marjan Mahboubifar, Rayhaneh Eskandari

Published in: Malaria Journal | Issue 1/2019

Login to get access

Abstract

Background

After years of efforts on the control of malaria, it remains as a most deadly infectious disease. A major problem for the available anti-malarial drugs is the occurrence of drug resistance in Plasmodium. Developing of new compounds or modification of existing anti-malarial drugs is an effective approach to face this challenge. Quantitative structure activity relationship (QSAR) modelling plays an important role in design and modification of anti-malarial compounds by estimation of the activity of the compounds.

Methods

In this research, the QSAR study was done on anti-malarial activity of 33 imidazolopiperazine compounds based on artificial neural networks (ANN). The structural descriptors of imidazolopiperazine molecules was used as the independents variables and their activity against 3D7 and W2 strains was used as the dependent variables. During modelling process, 70% of compound was used as the training and two 15% of imidazolopiperazines were used as the validation and external test sets. In this work, stepwise multiple linear regression was applied as the valuable selection and ANN with Levenberg–Marquardt algorithm was utilized as an efficient non-linear approach to correlate between structural information of molecules and their anti-malarial activity.

Results

The sufficiency of the suggested method to estimate the anti-malarial activity of imidazolopiperazine compounds at two 3D7 and W2 strains was demonstrated using statistical parameters, such as correlation coefficient (R2), mean square error (MSE). For instance R2train = 0.947, R2val = 0.959, R2test = 0.920 shows the potential of the suggested model for the prediction of 3D7 activity. Different statistical approaches such as and applicability domain (AD) and y-scrambling was also showed the validity of models.

Conclusion

QSAR can be an efficient way to virtual screening the molecules to design more efficient compounds with activity against malaria (3D7 and W2 strains). Imidazolopiperazines can be good candidates and change in the structure and functional groups can be done intelligently using QSAR approach to rich more efficient compounds with decreasing trial–error runs during synthesis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mishra M, Mishra VK, Kashaw V, Iyer AK, Kashaw SK. Comprehensive review on various strategies for antimalarial drug discovery. Eur J Med Chem. 2017;125:1300–20.CrossRef Mishra M, Mishra VK, Kashaw V, Iyer AK, Kashaw SK. Comprehensive review on various strategies for antimalarial drug discovery. Eur J Med Chem. 2017;125:1300–20.CrossRef
2.
go back to reference Biamonte MA, Wanner J, Le Roch KG. Recent advances in malaria drug discovery. Bioorg Med Chem Lett. 2013;23:2829–43.CrossRef Biamonte MA, Wanner J, Le Roch KG. Recent advances in malaria drug discovery. Bioorg Med Chem Lett. 2013;23:2829–43.CrossRef
4.
go back to reference Flannery EL, Chatterjee AK, Winzeler EA. Antimalarial drug discovery—approaches and progress towards new medicines. Nat Rev Microbiol. 2013;11:849–62.CrossRef Flannery EL, Chatterjee AK, Winzeler EA. Antimalarial drug discovery—approaches and progress towards new medicines. Nat Rev Microbiol. 2013;11:849–62.CrossRef
5.
go back to reference Calderón F, Wilson DM, Gamo F-J. Antimalarial drug discovery: recent progress and future directions. Prog Med Chem. 2013;52:97–151.CrossRef Calderón F, Wilson DM, Gamo F-J. Antimalarial drug discovery: recent progress and future directions. Prog Med Chem. 2013;52:97–151.CrossRef
6.
go back to reference Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: applications to targets and beyond. Br J Pharmacol. 2007;152:21–37.CrossRef Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: applications to targets and beyond. Br J Pharmacol. 2007;152:21–37.CrossRef
7.
go back to reference Kumar Ojha P, Roy K. The current status of antimalarial drug research with special reference to application of QSAR models. Comb Chem High Throughput Screen. 2015;18:91–128.CrossRef Kumar Ojha P, Roy K. The current status of antimalarial drug research with special reference to application of QSAR models. Comb Chem High Throughput Screen. 2015;18:91–128.CrossRef
8.
go back to reference Agrawal VK, Srivastava R, Khadikar PV. QSAR Studies on some antimalarial sulfonamides. Bioorg Med Chem. 2001;9:3287–93.CrossRef Agrawal VK, Srivastava R, Khadikar PV. QSAR Studies on some antimalarial sulfonamides. Bioorg Med Chem. 2001;9:3287–93.CrossRef
9.
go back to reference Cheng F, Shen J, Luo X, Zhu W, Gu J, Ji R, et al. Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues. Bioorg Med Chem. 2002;10:2883–91.CrossRef Cheng F, Shen J, Luo X, Zhu W, Gu J, Ji R, et al. Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues. Bioorg Med Chem. 2002;10:2883–91.CrossRef
10.
go back to reference Katritzky AR, Kulshyn OV, Stoyanova-Slavova I, Dobchev DA, Kuanar M, Fara DC, et al. Antimalarial activity: a QSAR modeling using CODESSA PRO software. Bioorg Med Chem. 2006;14:2333–57.CrossRef Katritzky AR, Kulshyn OV, Stoyanova-Slavova I, Dobchev DA, Kuanar M, Fara DC, et al. Antimalarial activity: a QSAR modeling using CODESSA PRO software. Bioorg Med Chem. 2006;14:2333–57.CrossRef
11.
go back to reference Cardoso FJB, de Figueiredo AF, da Silva Lobato M, de Miranda RM, de Almeida RCO, Pinheiro JC. A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR. J Mol Model. 2008;14:39–48.CrossRef Cardoso FJB, de Figueiredo AF, da Silva Lobato M, de Miranda RM, de Almeida RCO, Pinheiro JC. A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR. J Mol Model. 2008;14:39–48.CrossRef
12.
go back to reference Cheoymang A, Na-Bangchang K. A systematic review: application of in silico models for antimalarial drug discovery. Afr J Pharm Pharmacol. 2018;12:159–67.CrossRef Cheoymang A, Na-Bangchang K. A systematic review: application of in silico models for antimalarial drug discovery. Afr J Pharm Pharmacol. 2018;12:159–67.CrossRef
13.
go back to reference Leong FJ, Zhao R, Zeng S, Magnusson B, Diagana TT, Pertel P. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob Agents Chemother. 2014;58:6437–43.CrossRef Leong FJ, Zhao R, Zeng S, Magnusson B, Diagana TT, Pertel P. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob Agents Chemother. 2014;58:6437–43.CrossRef
14.
go back to reference Chia PY, Hsu LY, Yeo TW. Malaria in 2018: looking to the past and moving into the future. Ann Acad Med. 2018;47:4. Chia PY, Hsu LY, Yeo TW. Malaria in 2018: looking to the past and moving into the future. Ann Acad Med. 2018;47:4.
15.
go back to reference Nagle A, Wu T, Kuhen K, Gagaring K, Borboa R, Francek C, et al. Imidazolopiperazines: lead optimization of the second-generation antimalarial agents. J Med Chem. 2012;55:4244–73.CrossRef Nagle A, Wu T, Kuhen K, Gagaring K, Borboa R, Francek C, et al. Imidazolopiperazines: lead optimization of the second-generation antimalarial agents. J Med Chem. 2012;55:4244–73.CrossRef
16.
go back to reference Wu T, Nagle A, Kuhen K, Gagaring K, Borboa R, Francek C, et al. Imidazolopiperazines: hit to lead optimization of new antimalarial agents. J Med Chem. 2011;54:5116–30.CrossRef Wu T, Nagle A, Kuhen K, Gagaring K, Borboa R, Francek C, et al. Imidazolopiperazines: hit to lead optimization of new antimalarial agents. J Med Chem. 2011;54:5116–30.CrossRef
17.
go back to reference Todeschini R, Consonni V. Molecular descriptors for chemoinformatics. 2nd ed. Weinheim: WILEY-VCH; 2009.CrossRef Todeschini R, Consonni V. Molecular descriptors for chemoinformatics. 2nd ed. Weinheim: WILEY-VCH; 2009.CrossRef
18.
go back to reference Mauri A, Consonni V, Pavan M, Todeschini R. Dragon software: an easy approach to molecular descriptor calculations. MATCH Commun Math Comput Chem. 2006;56:237–48. Mauri A, Consonni V, Pavan M, Todeschini R. Dragon software: an easy approach to molecular descriptor calculations. MATCH Commun Math Comput Chem. 2006;56:237–48.
19.
go back to reference Yousefinejad S, Hemmateenejad B. Chemometrics tools in QSAR/QSPR studies: a historical perspective. Chemom Intell Lab Syst. 2015;149:177–204.CrossRef Yousefinejad S, Hemmateenejad B. Chemometrics tools in QSAR/QSPR studies: a historical perspective. Chemom Intell Lab Syst. 2015;149:177–204.CrossRef
20.
go back to reference Yousefinejad S, Mahboubifar M, Rasekh S. Prediction of different antibacterial activity in a new set of formyl hydroxyamino derivatives with potent action on peptide deformylase using structural information. Struct Chem. 2019;30:925–36.CrossRef Yousefinejad S, Mahboubifar M, Rasekh S. Prediction of different antibacterial activity in a new set of formyl hydroxyamino derivatives with potent action on peptide deformylase using structural information. Struct Chem. 2019;30:925–36.CrossRef
21.
go back to reference Hawkins DM. The problem of overfitting. J Chem Inf Comput Sci. 2004;44:1–12.CrossRef Hawkins DM. The problem of overfitting. J Chem Inf Comput Sci. 2004;44:1–12.CrossRef
22.
go back to reference Gramatica P. External evaluation of QSAR models, in addition to cross-validation: verification of predictive capability on totally new chemicals. Mol Inform. 2014;33:311–4.CrossRef Gramatica P. External evaluation of QSAR models, in addition to cross-validation: verification of predictive capability on totally new chemicals. Mol Inform. 2014;33:311–4.CrossRef
23.
go back to reference Netzeva TI, Worth AP, Aldenberg T, Benigni R, Cronin MD, Gramatica P, et al. Current status of methods for defining the applicability domain of (quantitative) structure–activity relationships. Altern Lab Anim. 2005;33:155–73.CrossRef Netzeva TI, Worth AP, Aldenberg T, Benigni R, Cronin MD, Gramatica P, et al. Current status of methods for defining the applicability domain of (quantitative) structure–activity relationships. Altern Lab Anim. 2005;33:155–73.CrossRef
24.
go back to reference Sahigara F, Mansouri K, Ballabio D, Mauri A, Consonni V, Todeschini R. Comparison of different approaches to define the applicability domain of QSAR models. Molecules. 2012;17:4791–810.CrossRef Sahigara F, Mansouri K, Ballabio D, Mauri A, Consonni V, Todeschini R. Comparison of different approaches to define the applicability domain of QSAR models. Molecules. 2012;17:4791–810.CrossRef
25.
go back to reference Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb Sci. 2007;26:694–701.CrossRef Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb Sci. 2007;26:694–701.CrossRef
26.
go back to reference Yousefinejad S, Honarasa F, Montaseri H. Linear solvent structure-polymer solubility and solvation energy relationships to study conductive polymer/carbon nanotube composite solutions. RSC Adv. 2015;5:42266–75.CrossRef Yousefinejad S, Honarasa F, Montaseri H. Linear solvent structure-polymer solubility and solvation energy relationships to study conductive polymer/carbon nanotube composite solutions. RSC Adv. 2015;5:42266–75.CrossRef
27.
go back to reference Dimitrov S, Dimitrova G, Pavlov T, Dimitrova N, Patlewicz G, Niemela J, et al. A stepwise approach for defining the applicability domain of SAR and QSAR models. J Chem Inf Model. 2005;45:839–49.CrossRef Dimitrov S, Dimitrova G, Pavlov T, Dimitrova N, Patlewicz G, Niemela J, et al. A stepwise approach for defining the applicability domain of SAR and QSAR models. J Chem Inf Model. 2005;45:839–49.CrossRef
28.
go back to reference Honarasa F, Yousefinejad S, Nasr S, Nekoeina M. Structure–electrochemistry relationship in non-aqueous solutions: predicting the reduction potential of anthraquinones derivatives in some organic solvents. J Mol Liq. 2015;212:52–7.CrossRef Honarasa F, Yousefinejad S, Nasr S, Nekoeina M. Structure–electrochemistry relationship in non-aqueous solutions: predicting the reduction potential of anthraquinones derivatives in some organic solvents. J Mol Liq. 2015;212:52–7.CrossRef
29.
go back to reference Yousefinejad S, Eftekhari R, Honarasa F, Zamanian Z, Sedaghati F. Comparison between the gas–liquid solubility of methanol and ethanol in different organic phases using structural properties of solvents. J Mol Liq. 2017;241:861–9.CrossRef Yousefinejad S, Eftekhari R, Honarasa F, Zamanian Z, Sedaghati F. Comparison between the gas–liquid solubility of methanol and ethanol in different organic phases using structural properties of solvents. J Mol Liq. 2017;241:861–9.CrossRef
30.
go back to reference Yasri A, Hartsough D. Toward an optimal procedure for variable selection and QSAR model building. J Chem Inf Comput Sci. 2001;41:1218–27.CrossRef Yasri A, Hartsough D. Toward an optimal procedure for variable selection and QSAR model building. J Chem Inf Comput Sci. 2001;41:1218–27.CrossRef
31.
go back to reference Yoo W, Mayberry R, Bae S, Singh K, He QP, Lillard JW Jr. A study of effects of multicollinearity in the multivariable analysis. Int J Appl Sci Technol. 2014;4:9.PubMedPubMedCentral Yoo W, Mayberry R, Bae S, Singh K, He QP, Lillard JW Jr. A study of effects of multicollinearity in the multivariable analysis. Int J Appl Sci Technol. 2014;4:9.PubMedPubMedCentral
32.
go back to reference Alin A. Multicollinearity. Wiley Interdiscip Rev Comput Stat. 2010;2:370–4.CrossRef Alin A. Multicollinearity. Wiley Interdiscip Rev Comput Stat. 2010;2:370–4.CrossRef
Metadata
Title
Quantitative structure–activity relationship to predict the anti-malarial activity in a set of new imidazolopiperazines based on artificial neural networks
Authors
Saeed Yousefinejad
Marjan Mahboubifar
Rayhaneh Eskandari
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Antimalaria
Published in
Malaria Journal / Issue 1/2019
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-019-2941-5

Other articles of this Issue 1/2019

Malaria Journal 1/2019 Go to the issue